{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:53:13Z","timestamp":1790855593382,"version":"4.1.0"},"reference-count":141,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.neuroscience.2020.03.009","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T07:05:02Z","timestamp":1584428702000},"page":"48-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["ANTIBODIES AND RECEPTORS: From Neuromuscular Junction to Central Nervous System"],"prefix":"10.1016","volume":"439","author":[{"given":"Angela","family":"Vincent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.neuroscience.2020.03.009_b0010","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1432-1033.1993.tb18027.x","article-title":"Primary structure of the human muscle acetylcholine receptor. cDNA cloning of the gamma and epsilon subunits","volume":"215","author":"Beeson","year":"1993","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0015","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaut.2013.12.011","article-title":"Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms","volume":"52","author":"Berrih-Aknin","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0020","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/00000658-193910000-00005","article-title":"Myasthenia gravis and tumors of the thymic region. Report of a case in which the tumor was removed","volume":"110","author":"Blalock","year":"1939","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.neuroscience.2020.03.009_b0025","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3390\/ijms19020490","article-title":"Fundamental molecules and mechanisms for forming and maintaining neuromuscular synapses","volume":"19","author":"Burden","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0030","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/mus.880130507","article-title":"A myasthenia gravis plasma immunoglobulin reduces miniature endplate potentials at human endplates in vitro","volume":"13","author":"Burges","year":"1990","journal-title":"Muscle Nerve"},{"issue":"Pt 8","key":"10.1016\/j.neuroscience.2020.03.009_b0035","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1093\/brain\/awu142","article-title":"Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes","volume":"137","author":"Carvajal-Gonzalez","year":"2014","journal-title":"Brain"},{"issue":"14","key":"10.1016\/j.neuroscience.2020.03.009_b0040","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1113\/JP277819","article-title":"Rapsyn facilitates recovery from desensitization in fetal and adult acetylcholine receptors expressed in a muscle cell line","volume":"597","author":"Cetin","year":"2019","journal-title":"J Physiol"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0045","doi-asserted-by":"crossref","unstructured":"Cetin H, Webster R, Liu WW, Nagaishi A, Koneczny I, Zimprich F, Maxwell S, Cossins J, Beeson D, Vincent A. Myasthenia gravis AChR antibodies inhibit function of rapsyn-clustered AChRs. J Neurol Neurosurg Psychiatr 2020 in press.","DOI":"10.1136\/jnnp-2019-322640"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0050","first-page":"241","article-title":"Isolation of neurotoxins from the venom of Bungarus multicinctus and their modes of neuromuscular blocking action","volume":"144","author":"Chang","year":"1962","journal-title":"Arch Pharmacodyn Ther"},{"issue":"3","key":"10.1016\/j.neuroscience.2020.03.009_b0055","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1073\/pnas.67.3.1241","article-title":"Use of a snake venom toxin to characterize the cholinergic receptor protein","volume":"67","author":"Changeux","year":"1970","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0060","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1113\/jphysiol.2010.190298","article-title":"Patient autoantibodies deplete postsynaptic muscle-specific kinase leading to disassembly of the ACh receptor scaffold and myasthenia gravis in mice","volume":"588","author":"Cole","year":"2010","journal-title":"J Physiol"},{"issue":"3","key":"10.1016\/j.neuroscience.2020.03.009_b0065","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/brain\/103.3.579","article-title":"Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis","volume":"103","author":"Compston","year":"1980","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.neuroscience.2020.03.009_b0070","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1136\/jnnp-2016-315251","article-title":"CASPR2 autoantibodies are raised during pregnancy in mothers of children with mental retardation and disorders of psychological development but not autism","volume":"88","author":"Coutinho","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.neuroscience.2020.03.009_b0075","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00401-017-1751-5","article-title":"Persistent microglial activation and synaptic loss with behavioral abnormalities in mouse offspring exposed to CASPR2-antibodies in utero","volume":"134","author":"Coutinho","year":"2017","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0080","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1113\/jphysiol.1982.sp014451","article-title":"Denervation changes in normal and myasthenia gravis human muscle fibres during organ culture","volume":"333","author":"Cull-Candy","year":"1982","journal-title":"J Physiol"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0085","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1113\/jphysiol.1980.sp013145","article-title":"On the release of transmitter at normal, myasthenia gravis and myasthenic syndrome affected human end-plates","volume":"299","author":"Cull-Candy","year":"1980","journal-title":"J Physiol"},{"issue":"5772","key":"10.1016\/j.neuroscience.2020.03.009_b0090","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/286500a0","article-title":"Diffusion of acetylcholine in the synaptic cleft of normal and myasthenia gravis human endplates","volume":"286","author":"Cull-Candy","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0095","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1113\/jphysiol.1936.sp003371","article-title":"Release of acetylcholine at voluntary motor nerve endings","volume":"86","author":"Dale","year":"1936","journal-title":"J Physiol"},{"issue":"2","key":"10.1016\/j.neuroscience.2020.03.009_b0100","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1152\/physrev.00010.2016","article-title":"Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune diseases of the central nervous system","volume":"97","author":"Dalmau","year":"2017","journal-title":"Physiol Rev"},{"issue":"12","key":"10.1016\/j.neuroscience.2020.03.009_b0105","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.neuroscience.2020.03.009_b0110","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1474-4422(08)70060-7","article-title":"Paraneoplastic syndromes of the CNS","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.neuroscience.2020.03.009_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2018.01.033","article-title":"Immune or genetic-mediated disruption of CASPR2 causes pain hypersensitivity due to enhanced primary afferent excitability","volume":"97","author":"Dawes","year":"2018","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.neuroscience.2020.03.009_b0120","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0092-8674(00)81251-9","article-title":"The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo","volume":"85","author":"DeChiara","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0125","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1056\/NEJM198209233071301","article-title":"Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis","volume":"307","author":"Drachman","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0130","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJM197805182982004","article-title":"Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation. A34N","volume":"298","author":"Drachman","year":"1978","journal-title":"Engl J Med"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0135","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1113\/jphysiol.1964.sp007495","article-title":"An electrophysiological investigation of neuromuscular transmission in myasthenia gravis","volume":"174","author":"Elmqvist","year":"1964","journal-title":"J Physiol (Lond)"},{"issue":"4","key":"10.1016\/j.neuroscience.2020.03.009_b0140","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1212\/WNL.27.4.307","article-title":"Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model","volume":"27","author":"Engel","year":"1977","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neuroscience.2020.03.009_b0145","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1474-4422(14)70201-7","article-title":"Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment","volume":"14","author":"Engel","year":"2015","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.neuroscience.2020.03.009_b0150","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/ana.410160502","article-title":"Myasthenia gravis and myasthenic syndromes","volume":"16","author":"Engel","year":"1984","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0155","first-page":"267","article-title":"Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations","volume":"52","author":"Engel","year":"1977","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0160","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/BF02666475","article-title":"Zur casuistik der bulb\u00e4ren l\u00e4hmungen","volume":"9","author":"Erb","year":"1879","journal-title":"Arch Psychiatr Nervenkr"},{"issue":"Pt 10","key":"10.1016\/j.neuroscience.2020.03.009_b0165","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/brain\/awg223","article-title":"Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis","volume":"126","author":"Evoli","year":"2003","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.neuroscience.2020.03.009_b0170","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/jnnp-2016-315480","article-title":"Nodes, paranodes and neuropathies","volume":"89","author":"Fehmi","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4109","key":"10.1016\/j.neuroscience.2020.03.009_b0175","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1126\/science.182.4109.293","article-title":"Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors","volume":"182","author":"Fambrough","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0180","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/awl095","article-title":"MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis","volume":"129","author":"Farrugia","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0185","doi-asserted-by":"crossref","first-page":"7636","DOI":"10.1073\/pnas.80.24.7636","article-title":"Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones","volume":"80","author":"Fukunaga","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.neuroscience.2020.03.009_b0190","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1172\/JCI125178","article-title":"Autoimmune seizures and epilepsy","volume":"129","author":"Geis","year":"2019","journal-title":"J Clin Invest"},{"issue":"13","key":"10.1016\/j.neuroscience.2020.03.009_b0195","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1113\/jphysiol.2013.270207","article-title":"Muscle-specific kinase (MuSK) autoantibodies suppress the MuSK pathway and ACh receptor retention at the mouse neuromuscular junction","volume":"592","author":"Ghazanfari","year":"2014","journal-title":"J Physiol"},{"issue":"7","key":"10.1016\/j.neuroscience.2020.03.009_b0200","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1093\/brain\/awz119","article-title":"Behaviour and neuropathology in mice injected with human contactin-associated protein 2 antibodies","volume":"142","author":"Giannoccaro","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0205","unstructured":"Giannoccaro MP, Wright S, Vincent A. Animal models of antibody-mediated diseases. Front Immunol 2020 in press. Review."},{"issue":"1","key":"10.1016\/j.neuroscience.2020.03.009_b0210","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","volume":"5","author":"Gilhus","year":"2019","journal-title":"Myasthenia gravis Nat Rev Dis Primers"},{"issue":"3","key":"10.1016\/j.neuroscience.2020.03.009_b0215","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10286-019-00611-1","article-title":"Autoimmune autonomic neuropathies and ganglionopathies: epidemiology, pathophysiology, and therapeutic advances","volume":"29","author":"Golden","year":"2019","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0220","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/BF01665294","article-title":"Ueber einen scheinbar heilbaren bulbar paralytischen Symptomencomplex mit Betheiligung der Extremit\u00e4ten","volume":"4","author":"Goldflam","year":"1893","journal-title":"Dtsch Z Nervenheilkd"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0225","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/bs.pmbts.2017.12.010","article-title":"Gangliosides and autoimmune peripheral nerve diseases","volume":"156","author":"Goodfellow","year":"2018","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"1094","key":"10.1016\/j.neuroscience.2020.03.009_b0230","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1098\/rspb.1975.0041","article-title":"Neuromuscular transmission after immunization against acetylcholine receptors","volume":"189","author":"Green","year":"1975","journal-title":"Proc R Soc Lond B Biol Sci"},{"issue":"908","key":"10.1016\/j.neuroscience.2020.03.009_b9010","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1098\/rstb.1975.0031","article-title":"Acetylcholine receptors","volume":"270","author":"Green","year":"1975","journal-title":"Philos Trans R Soc Lond B Biol Sci."},{"issue":"1","key":"10.1016\/j.neuroscience.2020.03.009_b0235","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1172\/JCI1248","article-title":"Regulation of acetylcholine receptor gene expression in human myasthenia gravis muscles. Evidences for a compensatory mechanism triggered by receptor loss","volume":"102","author":"Guyon","year":"1998","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.neuroscience.2020.03.009_b0240","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000057","article-title":"Fetal acetylcholine receptor inactivation syndrome: A myopathy due to maternal antibodies","volume":"2","author":"Hacohen","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0245","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1093\/brain\/awf178","article-title":"Phenotypic variants of autoimmune peripheral nerve hyperexcitability","volume":"125","author":"Hart","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0250","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/ana.410410215","article-title":"Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia","volume":"41","author":"Hart","year":"1997","journal-title":"Ann Neurol"},{"issue":"11","key":"10.1016\/j.neuroscience.2020.03.009_b0255","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1212\/WNL.38.11.1784","article-title":"Anti-acetylcholine receptor antibody specificities in serum and in thymic cell culture supernatants from myasthenia gravis patients","volume":"38","author":"Heidenreich","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0260","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/B978-0-444-63432-0.00021-9","article-title":"Autoimmune AQP4 channelopathies and neuromyelitis optica spectrum disorders","volume":"133","author":"Hinson","year":"2016","journal-title":"Handb Clin Neurol"},{"issue":"3","key":"10.1016\/j.neuroscience.2020.03.009_b0265","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.neuroscience.2020.03.009_b0270","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000645","article-title":"SHP2 inhibitor protects AChRs from effects of myasthenia gravis MuSK antibody","volume":"7","author":"Huda","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0275","doi-asserted-by":"crossref","first-page":"20783","DOI":"10.1073\/pnas.1313944110","article-title":"MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4","volume":"110","author":"Huijbers","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0280","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.neuroscience.2020.03.009_b0285","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ana.22307","article-title":"Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis","volume":"69","author":"Irani","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0290","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ana.23577","article-title":"Morvan syndrome: clinical and serological observations in 29 cases","volume":"72","author":"Irani","year":"2012","journal-title":"Ann Neurol"},{"issue":"1109","key":"10.1016\/j.neuroscience.2020.03.009_b0295","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1098\/rspb.1976.0025","article-title":"Acetylcholine in human muscle","volume":"192","author":"Ito","year":"1976","journal-title":"Proc R Soc Lond B Biol Sci"},{"issue":"2","key":"10.1016\/j.neuroscience.2020.03.009_b0300","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/brain\/101.2.345","article-title":"Acetylcholine receptors and end-plate electrophysiology in myasthenia gravis","volume":"101","author":"Ito","year":"1978","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0305","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1001\/archneurol.2012.437","article-title":"Presence and pathogenic relevance of antibodies to clustered acetylcholine receptor in ocular and generalized myasthenia gravis","volume":"69","author":"Jacob","year":"2012","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1016\/j.neuroscience.2020.03.009_b0310","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0165-5728(99)00086-7","article-title":"Monoclonal antibodies raised against human acetylcholine receptor bind to all five subunits of the fetal isoform","volume":"98","author":"Jacobson","year":"1999","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0315","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1172\/JCI5943","article-title":"An animal model of antibody-mediated neurodevelopmental disease: arythrogryposis multiplex congenita caused by antibodies to fetal acetylcholine receptor","volume":"103","author":"Jacobson","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0320","first-page":"1","article-title":"Ueber Myasthenia gravis pseudoparalytica","volume":"32","author":"Jolly","year":"1895","journal-title":"Berl Klin Wochenschr"},{"issue":"Pt 4","key":"10.1016\/j.neuroscience.2020.03.009_b0325","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/brain\/aws025","article-title":"Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice","volume":"135","author":"Klooster","year":"2012","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.neuroscience.2020.03.009_b0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080695","article-title":"MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters","volume":"8","author":"Koneczny","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0335","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jaut.2016.11.005","article-title":"IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients","volume":"77","author":"Koneczny","year":"2017","journal-title":"J Autoimmun"},{"issue":"5639","key":"10.1016\/j.neuroscience.2020.03.009_b0340","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/270739a0","article-title":"Acetylcholine receptors in the oocyte membrane","volume":"270","author":"Kusano","year":"1977","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.neuroscience.2020.03.009_b0345","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S1474-4422(10)70137-X","article-title":"Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series","volume":"9","author":"Lai","year":"2010","journal-title":"Lancet Neurol"},{"issue":"11","key":"10.1016\/j.neuroscience.2020.03.009_b0350","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/mus.880111105","article-title":"Selected IgG rapidly induces Lambert-Eaton myasthenic syndrome in mice: complement independence and EMG abnormalities","volume":"11","author":"Lambert","year":"1988","journal-title":"Muscle Nerve"},{"issue":"8240","key":"10.1016\/j.neuroscience.2020.03.009_b0355","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0140-6736(81)90474-8","article-title":"Autoimmune aetiology for myasthenic (Eaton-Lambert) syndrome","volume":"2","author":"Lang","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0360","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/brain\/awn092","article-title":"IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis","volume":"131","author":"Leite","year":"2008","journal-title":"Brain"},{"issue":"22","key":"10.1016\/j.neuroscience.2020.03.009_b0365","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1056\/NEJM199506013322203","article-title":"Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes","volume":"332","author":"Lennon","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0370","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1093\/brain\/124.12.2417","article-title":"Morvan\u2019s syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels","volume":"124","author":"Liguori","year":"2001","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.neuroscience.2020.03.009_b0375","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1212\/WNL.26.11.1054","article-title":"Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value","volume":"26","author":"Lindstrom","year":"1976","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0380","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1212\/WNL.26.11.1054","article-title":"Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates and diagnostic value","volume":"26","author":"Lindstrom","year":"1976","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0385","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF01738910","article-title":"\u00dcber humorale \u00dcbertragbarkeit der Herznervenwirkung","volume":"189","author":"Loewi","year":"1921","journal-title":"Pfl\u00fcgers Arch ges Physiol"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0390","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/mus.20536","article-title":"Clinical, electrophysiological characterization of the acquired neuromyotonia phenotype of autoimmune peripheral nerve hyperexcitability","volume":"33","author":"Maddison","year":"2006","journal-title":"Muscle Nerve"},{"issue":"7","key":"10.1016\/j.neuroscience.2020.03.009_b0395","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/(SICI)1097-4598(199907)22:7<823::AID-MUS3>3.0.CO;2-1","article-title":"Strength-duration properties of peripheral nerve in acquired neuromyotonia","volume":"22","author":"Maddison","year":"1999","journal-title":"Muscle Nerve"},{"issue":"10","key":"10.1016\/j.neuroscience.2020.03.009_b0400","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/01.LAB.0000032379.63784.9C","article-title":"Antibodies to acetylcholine receptor in parous women with myasthenia: evidence for immunization by fetal antigen","volume":"82","author":"Matthews","year":"2002","journal-title":"Lab Invest"},{"issue":"4","key":"10.1016\/j.neuroscience.2020.03.009_b0405","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ana.20061","article-title":"Detection and characterization of MuSK antibodies in seronegative myasthenia gravis","volume":"55","author":"McConville","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0410","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/272641a0","article-title":"Alpha-Bungarotoxin enhances transmitter \u201creleased\u201d at the neuromuscular junction","volume":"272","author":"Miledi","year":"1978","journal-title":"Nature"},{"issue":"5286","key":"10.1016\/j.neuroscience.2020.03.009_b0415","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/229554a0","article-title":"Isolation of the cholinergic receptor protein of Torpedo electric tissue","volume":"229","author":"Miledi","year":"1971","journal-title":"Nature"},{"issue":"5322","key":"10.1016\/j.neuroscience.2020.03.009_b0420","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/233599a0","article-title":"Acetylcholine receptors in muscle fibres","volume":"233","author":"Miledi","year":"1971","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0425","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1113\/jphysiol.1960.sp006417","article-title":"Junctional and extra-junctional acetylcholine receptors in skeletal muscle fibres","volume":"151","author":"Miledi","year":"1960","journal-title":"J Physiol"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1113\/jphysiol.1960.sp006416","article-title":"The acetylcholine sensitivity of frog muscle fibres after complete or partial devervation","volume":"151","author":"Miledi","year":"1960","journal-title":"J Physiol"},{"issue":"6068","key":"10.1016\/j.neuroscience.2020.03.009_b0435","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/321406a0","article-title":"Molecular distinction between fetal and adult forms of muscle acetylcholine receptor","volume":"321","author":"Mishina","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0440","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/j.1471-4159.1981.tb04657.x","article-title":"Choline acetyltransferase in skeletal muscle from patients with myasthenia gravis","volume":"37","author":"Molenaar","year":"1981","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0445","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0079-6123(08)64657-9","article-title":"Acetylcholine in intercostal muscle from myasthenia gravis patients and in rat diaphragm after blockade of acetylcholine receptors","volume":"49","author":"Molenaar","year":"1979","journal-title":"Prog Brain Res"},{"issue":"2","key":"10.1016\/j.neuroscience.2020.03.009_b0450","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.expneurol.2012.06.034","article-title":"Muscle specific kinase autoantibodies cause synaptic failure through progressive wastage of postsynaptic acetylcholine receptors","volume":"237","author":"Morsch","year":"2012","journal-title":"Exp Neurol"},{"issue":"8473","key":"10.1016\/j.neuroscience.2020.03.009_b0455","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0140-6736(86)92259-2","article-title":"Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity","volume":"1","author":"Mossman","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0460","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/jnnp.58.1.85","article-title":"An improved diagnostic assay for Lambert-Eaton myasthenic syndrome","volume":"58","author":"Motomura","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Pt 2","key":"10.1016\/j.neuroscience.2020.03.009_b0465","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/brain\/116.2.453","article-title":"Immunological associations of acquired neuromyotonia (Isaacs' syndrome). Report of five cases and literature review","volume":"116","author":"Newsom-Davis","year":"1993","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.neuroscience.2020.03.009_b0470","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1212\/WNL.28.3.266","article-title":"Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange","volume":"28","author":"Newsom-Davis","year":"1978","journal-title":"Neurology"},{"issue":"5886","key":"10.1016\/j.neuroscience.2020.03.009_b0475","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/299793a0","article-title":"Primary structure of alpha-subunit precursor of Torpedo californica acetylcholine receptor deduced from cDNA sequence","volume":"299","author":"Noda","year":"1982","journal-title":"Nature"},{"issue":"Pt 1","key":"10.1016\/j.neuroscience.2020.03.009_b0480","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1101\/SQB.1983.048.01.008","article-title":"Molecular structure of the nicotinic acetylcholine receptor","volume":"48","author":"Numa","year":"1983","journal-title":"Cold Spring Harb Symp Quant Biol"},{"issue":"4088","key":"10.1016\/j.neuroscience.2020.03.009_b0485","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.180.4088.871","article-title":"Autoimmune response to acetylcholine receptor","volume":"180","author":"Patrick","year":"1973","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.neuroscience.2020.03.009_b0490","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ana.25120","article-title":"Mechanisms of Caspr2 antibodies in autoimmune encephalitis and neuromyotonia","volume":"83","author":"Patterson","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0495","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0304-3940(93)90073-T","article-title":"Cross-linking of presynaptic calcium channels: a mechanism of action for Lambert-Eaton myasthenic syndrome antibodies at the mouse neuromuscular junction","volume":"153","author":"Peers","year":"1993","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0500","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/ana.410370513","article-title":"Acetylcholine release in myasthenia gravis: regulation at single end-plate level","volume":"37","author":"Plomp","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0505","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/ana.410170610","article-title":"Action of Lambert-Eaton myasthenic syndrome IgG at mouse motor nerve terminals","volume":"17","author":"Prior","year":"1985","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.neuroscience.2020.03.009_b0510","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41582-018-0112-x","article-title":"Myelin oligodendrocyte glycoprotein antibodies in neurological disease","volume":"15","author":"Reindl","year":"2019","journal-title":"Nat Rev Neurol"},{"issue":"10","key":"10.1016\/j.neuroscience.2020.03.009_b0515","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1172\/JCI119048","article-title":"Association of arthrogryposis multiplex congenita with maternal antibodies inhibiting fetal acetylcholine receptor function","volume":"98","author":"Riemersma","year":"1996","journal-title":"J Clin Invest"},{"issue":"6039","key":"10.1016\/j.neuroscience.2020.03.009_b0520","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/317737a0","article-title":"Paraneoplastic myasthenic syndrome IgG inhibits 45Ca2+ flux in a human small cell carcinoma line","volume":"317","author":"Roberts","year":"1985","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.neuroscience.2020.03.009_b0525","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/jamaneurol.2015.0203","article-title":"Clinical features and diagnostic usefulness of antibodies to clustered acetylcholine receptors in the diagnosis of seronegative myasthenia gravis","volume":"72","author":"Rodriguez Cruz","year":"2015","journal-title":"JAMA Neurol"},{"issue":"3","key":"10.1016\/j.neuroscience.2020.03.009_b0530","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ana.410430315","article-title":"End-plate voltage-gated sodium channels are lost in clinical and experimental myasthenia gravis","volume":"43","author":"Ruff","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0535","first-page":"746","article-title":"Thymektomie bei einem Fall von Morbus Basedowi mit Myastheine","volume":"25","author":"Sauerbruch","year":"1913","journal-title":"Mitteil Grenzgeb Med Chir"},{"issue":"8","key":"10.1016\/j.neuroscience.2020.03.009_b0540","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1212\/WNL.31.8.935","article-title":"Acetylcholine receptor antibody synthesis by thymic lymphocytes: correlation with thymic histology","volume":"31","author":"Scadding","year":"1981","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0545","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ana.410220205","article-title":"Acetylcholine receptors in human thymic myoid cells in situ: an immunohistological study","volume":"22","author":"Schluep","year":"1987","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.neuroscience.2020.03.009_b0550","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2119\/molmed.2015.00232","article-title":"Genome-wide association study of late-onset myasthenia gravis: confirmation of TNFRSF11A and identification of ZBTB10 and three distinct HLA associations","volume":"21","author":"Seldin","year":"2016","journal-title":"Mol Med"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0555","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/ana.410380505","article-title":"Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves","volume":"38","author":"Shillito","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0560","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/003693306000501001","article-title":"Myasthenia gravis, a new hypothesis","volume":"5","author":"Simpson","year":"1960","journal-title":"Scott Med J"},{"issue":"4","key":"10.1016\/j.neuroscience.2020.03.009_b0565","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.4049\/jimmunol.167.4.1935","article-title":"Somatic hypermutation and selection of B cells in thymic germinal centers responding to acetylcholine receptor in myasthenia gravis","volume":"167","author":"Sims","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0570","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0140-6736(91)90073-X","article-title":"Autoimmune aetiology for acquired neuromyotonia (Isaacs' syndrome)","volume":"338","author":"Sinha","year":"1991","journal-title":"Lancet"},{"issue":"Pt 2","key":"10.1016\/j.neuroscience.2020.03.009_b0575","first-page":"451","article-title":"Structure and function of neuromuscular junctions in the vastus lateralis of man. A motor point biopsy study of two groups of patients","volume":"115","author":"Slater","year":"1992","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2020.03.009_b6575","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.neuroscience.2019.05.017","article-title":"\u2018Fragmentation\u2019 of NMJs: a sign of degeneration or regeneration? A long journey with many junctions","volume":"439","author":"Slater","year":"2020","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.neuroscience.2020.03.009_b0585","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/brain\/awx323","article-title":"The importance of early immunotherapy in patients with faciobrachial dystonic seizures","volume":"141","author":"Thompson","year":"2018","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.neuroscience.2020.03.009_b0590","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJM197701202960301","article-title":"Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice","volume":"296","author":"Toyka","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0595","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1126\/science.1179220","article-title":"Myasthenia gravis: passive transfer from man to mouse","volume":"190","author":"Toyka","year":"1975","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0600","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1073\/pnas.79.1.188","article-title":"Specificities of antibodies to acetylcholine receptors in sera from myasthenia gravis patients measured by monoclonal antibodies","volume":"79","author":"Tzartos","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0605","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0896-6273(95)90146-9","article-title":"Receptor tyrosine kinase specific for the skeletal muscle lineage \u2013 expression in embryonic muscle, at the neuromuscular junction and after injury","volume":"3","author":"Valenzuela","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0610","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.expneurol.2012.01.025","article-title":"Passive and active immunization models of MuSK-Ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects","volume":"234","author":"Viegas","year":"2012","journal-title":"Exp Neurol"},{"issue":"Pt 3","key":"10.1016\/j.neuroscience.2020.03.009_b0615","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/brain\/awh077","article-title":"Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis","volume":"127","author":"Vincent","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0620","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0140-6736(95)92652-6","article-title":"Arthrogryposis multiplex congenita with maternal autoantibodies specific for a fetal antigen","volume":"346","author":"Vincent","year":"1995","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.neuroscience.2020.03.009_b0630","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1212\/WNL.33.10.1276","article-title":"Acetylcholine receptor antibody and clinical response to thymectomy in myasthenia gravis","volume":"33","author":"Vincent","year":"1983","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.neuroscience.2020.03.009_b0635","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1136\/jnnp.48.12.1246","article-title":"Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays","volume":"48","author":"Vincent","year":"1985","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.neuroscience.2020.03.009_b0640","first-page":"257","article-title":"Acetylcholine receptor antibody characteristics in myasthenia gravis. I. Patients with generalized myasthenia or disease restricted to ocular muscles","volume":"49","author":"Vincent","year":"1982","journal-title":"Clin Exp Immunol"},{"issue":"12","key":"10.1016\/j.neuroscience.2020.03.009_b0645","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1001\/jamaneurol.2018.2681","article-title":"Association of leucine-rich glioma inactivated protein 1, contactin-associated protein 2, and contactin 2 antibodies with clinical features and patient-reported pain in acquired neuromyotonia","volume":"75","author":"Vincent","year":"2018","journal-title":"JAMA Neurol"},{"issue":"8059","key":"10.1016\/j.neuroscience.2020.03.009_b0650","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0140-6736(78)90073-9","article-title":"In-vitro synthesis of anti-acetylcholine-receptor antibody by thymic lymphocytes in myasthenia gravis","volume":"1","author":"Vincent","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0655","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/256010a0","article-title":"New support for autoimmune basis of myasthenia gravis","volume":"256","author":"Vincent","year":"1975","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.neuroscience.2020.03.009_b0660","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/mus.880040407","article-title":"Congenital myasthenia: end-plate acetylcholine receptors and electrophysiology in five cases","volume":"4","author":"Vincent","year":"1981","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0665","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nri916","article-title":"Unravelling the pathogenesis of myasthenia gravis","volume":"2","author":"Vincent","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0670","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S0140-6736(00)94294-6","article-title":"Treatment of myasthenia gravis with physostigmine","volume":"1","author":"Walker","year":"1934","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.neuroscience.2020.03.009_b0675","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1212\/WNL.36.5.612","article-title":"Myasthenia gravis: monoclonal antihuman acetylcholine receptor antibodies used to analyze antibody specificities and responses to treatment","volume":"36","author":"Whiting","year":"1986","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.neuroscience.2020.03.009_b0680","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0165-5728(86)90006-8","article-title":"Monoclonal antibodies that distinguish between normal and denervated human acetylcholine receptor","volume":"11","author":"Whiting","year":"1986","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0685","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1196\/annals.1405.021","article-title":"Autoimmunizing mechanisms in thymoma and thymus","volume":"1132","author":"Willcox","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0690","unstructured":"Willis, T. De Anima Brutorum 404\u2013407 (Oxonii Theatro Sheldoniano, Oxford, 1672)."},{"issue":"5","key":"10.1016\/j.neuroscience.2020.03.009_b0695","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/jnnp.46.5.383","article-title":"Acetylcholine receptor turnover in mice with passively transferred myasthenia gravis. II. Receptor synthesis","volume":"46","author":"Wilson","year":"1983","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"10.1016\/j.neuroscience.2020.03.009_b0700","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0705","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1602489","article-title":"Randomized trial of thymectomy in myasthenia gravis","volume":"375","author":"Wolfe","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neuroscience.2020.03.009_b0710","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nature11348","article-title":"Lrp4 is a retrograde signal for presynaptic differentiation at neuromuscular synapses","volume":"489","author":"Yumoto","year":"2012","journal-title":"Nature"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452220301524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452220301524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:00:18Z","timestamp":1759680018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452220301524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":141,"alternative-id":["S0306452220301524"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2020.03.009","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ANTIBODIES AND RECEPTORS: From Neuromuscular Junction to Central Nervous System","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2020.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 IBRO. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}